ORI
KURA icon

Oak Ridge Investments’s Kura Oncology KURA Stock Holding History

Oak Ridge Investments’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-209,213
Closed -$2.88M – 181
2019
Q4 		$2.88M Sell
209,213
-49,542
-19% -$734K 0.21% 110
2019
Q3 		$3.92M Buy
+258,755
New +$4.61M 0.3% 98

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oak Ridge Investments's KURA Position: Q1 2020 in Review

Oak Ridge Investments sold out of Kura Oncology (KURA) in Q1 2020, closing a stake of 209,213 shares — an estimated $2.88M sold.

Oak Ridge Investments first reported a position in KURA in Q3 2019 and held it in 2 quarters. The position peaked at $3.92M in Q3 2019. 119 funds tracked by Wall St. Rank hold KURA as of Q1 2020.

  • Oak Ridge Investments reported no remaining Kura Oncology position as of Q1 2020 after selling out during the quarter.
  • Oak Ridge Investments sold 209,213 Kura Oncology shares in Q1 2020, an estimated $2.88M.
  • Oak Ridge Investments first reported a position in Kura Oncology in Q3 2019 and held it in 2 quarters.
  • Oak Ridge Investments's Kura Oncology position peaked at $3.92M in Q3 2019.
  • 119 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2020.

Based on Oak Ridge Investments's 13F filing for Q1 2020, filed 13 May 2020.